Healius announces on-market share buy-back
Filed with ASX · · 1 page · English
Healius Limited (ASX: HLS) today announces that the Board has approved an on-market share buy-back of up to $100 million over the next 12 months, in accordance with the terms of the Appendix 3C to be lodged with this announcement. The buy-back will be managed within the ‘10/12 limit’ permitted by the Corporations Act, and therefore does not require shareholder approval. Healius intends to conduct
Story so far
Earlier from Healius
- HLS - significant growth in results and progress on strategy
- HLS - Presentation of Half Year 2022 Results
- Acquisition of Agilex Biolabs
- VRT: Update on ACCC Court application on proposed acquisition
- Trading Update 1QFY22
Later from Healius
- Notification regarding unquoted securities - HLS
- Strategy Day Presentation
- Healius FY2022 YTD update and Adora Fertility completion
- Update - Notification of buy-back - HLS
- Application for quotation of securities - HLS
Follow Healius into a list and get an email when it puts out news.
Follow Healius